Ligand Pharmaceuticals (LGND) Change in Taxes (2019 - 2023)
Ligand Pharmaceuticals (LGND) reported Change in Taxes of -$10.2 million for Q3 2023, down 266.93% on a YoY basis from $6.1 million in Q3 2022, and down 189.43% sequentially from $11.4 million in Q2 2023.
Ligand Pharmaceuticals (LGND) Change in Taxes (2019 - 2023) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 5 years of Change in Taxes data on file, last reported at -$10.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10.18 Mn |
| Sep 30, 2023 | -10.18 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Mar 31, 2023 | 4.61 Mn |
| Mar 31, 2023 | 4.61 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Jun 30, 2022 | -2.98 Mn |
| Jun 30, 2022 | -2.98 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Sep 30, 2021 | -1.69 Mn |
| Sep 30, 2021 | -1.69 Mn |
| Jun 30, 2021 | -3.55 Mn |
| Jun 30, 2021 | -3.55 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Sep 30, 2020 | 3.35 Mn |
| Sep 30, 2020 | 3.35 Mn |